Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer.
Orellana TJ, Kim H, Beriwal S, Bhargava R, Berger J, Buckanovich RJ, Coffman LG, Courtney-Brooks M, Mahdi H, Olawaiye AB, Sukumvanich P, Taylor SE, Smith KJ, Lesnock JL.
Orellana TJ, et al. Among authors: taylor se.
Gynecol Oncol. 2022 Jan;164(1):129-135. doi: 10.1016/j.ygyno.2021.10.071. Epub 2021 Nov 2.
Gynecol Oncol. 2022.
PMID: 34740462